-
Nov 19, 2024 | 
mondaq.com | Lisa S. Mazur |Dale Van Demark |Amanda Enyeart |Marshall Jackson
The US Drug Enforcement Administration (DEA) further extended flexibilities that allow providers to
prescribe controlled substances via telemedicine without first
performing an in-person visit. The flexibilities were initially
provided during the COVID-19 public health emergency (PHE) and were
scheduled to expire on December 31, 2024. This extension extends
the flexibilities through December 31, 2025.
-
Oct 1, 2024 | 
mondaq.com | Dale Van Demark |Jennifer S. Geetter |Shawn Helms
The Texas Attorney General (AG) recently announced a "first-of-its-kind" settlement with a healthcare generative
artificial intelligence (AI) company, Pieces Technologies, Inc.,
resolving allegations that the company made a series of false and
misleading statements about the accuracy and safety of its AI
products.
-
Jul 30, 2024 | 
jdsupra.com | Jae Hyun Lee |Dale Van Demark
Trending in Telehealth highlights state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists and technology companies that deliver and facilitate the delivery of virtual care.
-
Jul 30, 2024 | 
natlawreview.com | Dale Van Demark
Skip to main content July 30, 2024 Volume XIV, Number 212 Legal Analysis. Expertly Written. Quickly Found.
-
Apr 24, 2024 | 
jdsupra.com | Jennifer S. Geetter |Daniel Gottlieb |Dale Van Demark
On March 13, 2024, Utah Governor Spencer Cox signed Utah State S.B. 149, the Artificial Intelligence Policy Act (the AI Act) into law, which amends the Utah consumer protection and privacy laws to require disclosure, in certain circumstances, of artificial intelligence (AI) use to consumers, effective May 1, 2024. Interestingly, the AI Act takes a bifurcated approach to the disclosure requirement.
-
Apr 23, 2024 | 
natlawreview.com | Dale Van Demark
Skip to main content April 23, 2024 Volume XIV, Number 114 Legal Analysis. Expertly Written. Quickly Found.
-
Mar 14, 2024 | 
natlawreview.com | Dale Van Demark
Skip to main content March 14, 2024 Volume XIV, Number 74 Legal Analysis. Expertly Written. Quickly Found.
-
Feb 19, 2024 | 
jdsupra.com | Joel Rush |Dale Van Demark |Patrick Zanayed
In an apparent attempt to shield physician practices from perceived abuses of close association with physician practice management (PPM) companies, a pending Oregon law could undermine a broad range of structures and transactions between physicians and laypersons. Potentially affected structures and transactions include loans, real estate leases, practice sales, national virtual care platforms, investor sponsored practice roll-ups and payor-provider joint ventures.
-
Dec 14, 2023 | 
jdsupra.com | Taylor Hood |Dale Van Demark
Trending in Telehealth highlights state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists and technology companies that deliver and facilitate the delivery of virtual care.
-
Dec 14, 2023 | 
natlawreview.com | Lynn L. Bergeson |Carla N. Hutton |Dale Van Demark |Taylor Hood
In Vans, Inc. v. MSCHF Product Studio, Inc., the first appellate court opinion to apply the U.S. Supreme Court’s decision in Jack Daniel’s Properties v. VIP Products, the U.S. Court of Appeals for the Second Circuit considered whether to recognize heightened First Amendment protection in a sneaker design and bypass the traditional likelihood of confusion analysis for trademark infringement suits.
